MOORSIDE PHARMA DEVELOPMENTS LIMITED
MOORSIDE PHARMA DEVELOPMENTS LIMITED is a private limited company registered in the United Kingdom, under 07930921, incorporated on 1 February 2012. The company is currently active. Operates in the dispensing chemist in specialised stores sector (SIC 47730). The company has been operating for 14 years. Registered office address: BD2 3AA Bradford, the United Kingdom. Directors include MR ANDREW JOHN BOYLE, DR STEVEN JOHN CLEASBY, and DR JONATHAN DAVID COLE, and 4 others. Sole shareholder is Rycroft Partnership Llp. Associated with 20 related entities, including 06772725, 07890426, and SPRING HALL GROUP PROPERTIES LTD. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Registered Address
372 DUDLEY HILL ROAD
WEST YORKSHIRE
BD2 3AA BRADFORD
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Source Records (1)
| companieshouse | 07930921 | 2026-06-01 | open_in_new |